article thumbnail

Seladelpar

New Drug Approvals

1] [2] [3] The compound was licensed from Janssen Pharmaceutica NV. [4] 2007 Jul 15;17(14):3855-9. Epub 2007 May 10. Seladelpar cas 851528-79-5 C 21 H 23 F 3 O 5 S, 444.47 1] It is used as the lysine dihydrate salt. [1] 1] It is a PPARδ receptor agonist. [1] Seladelpar works to block bile acid synthesis. doi: 10.1016/j.bmcl.2007.05.007.

FDA 62
article thumbnail

Investigating antipsychotics in a Parkinson’s disease psychosis model

Drug Target Review

Clozapine induced a significantly different brain state and pimavanserin, the only licensed compound for PD-P, turned out to be more similar to Mesdopetam on the global scale. During the years 2007-2010 he served as board member of SwedenBIO, the Swedish Biotech industry association. In 2013, Nicholas co-founded IRLAB Sweden.

Disease 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

VALILTRAMIPROSATE

New Drug Approvals

2007 ; Kocis et al., Alzheon licensed ALZ-801 from NeuroChem and is developing it for Alzheimer’s disease. ALZ-801 is converted to homotaurine in vivo, but is more easily absorbed and lasts longer in the blood than tramiprosate. Tramiprosate was reported to inhibit Aβ42 aggregation into toxic oligomers ( Gervais et al.,

article thumbnail

FDA More Selective About Convening Advisory Committee Panels During Pandemic | 2021-01-18

The Pharma Data

FDA advisory committees recommended just 50 percent of the 18 new therapies and indications they reviewed in 2020, the lowest rate since 2007, and the agency seems to be reserving the panels for more problematic applications, according to Prevision Policy, a Washington, D.C.-based based research firm.

FDA 52
article thumbnail

Janssen Announces Novel Mechanism of Action that Shows Promise Against Dengue in Data Published in Nature

The Pharma Data

The Janssen dengue compound discovery program started in 2007. licensed the compound series in 2015, and is continuing to advance the compound into clinical development. This effort built upon four years of work on the novel antiviral inhibitor by KU Leuven Rega Institute, CD3, and the Wellcome Trust. Janssen Pharmaceutica, N.V.

Virus 52
article thumbnail

Alzprotect Strengthens Its Intellectual Property Portfolio for Its First-in-Class Clinical Stage Drug Ezeprogind

The Pharma Data

Alzprotect co-owns or has an exclusive worldwide license from the French National Institute of Health and Medical research (Inserm) and the University of Lille (France) on a total of 58 patents related to Ezeprogind in 39 countries. Alzprotect is financed by the XERYS fund (Paris). About Alzprotect.

Drugs 40
article thumbnail

Treatment Plans That Worked

The Pharma Data

The Executive Director of the Institute for Behavior Change (IBC), licensed psychologist and certified school psychologist Steve Kossor, has been involved in the planning and delivery of what became known as Intensive Behavioral Health Services (IBHS) in Pennsylvania since 1981. push(arguments)},i[r].l=1*new Watch this video to learn more.